von Knorre G H
Abteilung für Kardiologie, Universität Rostock.
Z Gesamte Inn Med. 1993 Sep;48(9):453-8.
Thromboembolism is a frequent complication of atrial fibrillation. As could be demonstrated by several placebo-controlled prospective studies in the recent years the rate of thromboembolism was reduced significantly by anticoagulation of nearly all kinds of atrial fibrillation. These results are challenging to weigh risks and benefits in every patient. The principles which have to consider in this calculation are discussed with regard to the knowledge derived from the controlled studies.
血栓栓塞是心房颤动的常见并发症。近年来多项安慰剂对照前瞻性研究表明，几乎所有类型的心房颤动通过抗凝治疗后血栓栓塞发生率均显著降低。这些结果对于权衡每个患者的风险和益处具有挑战性。根据对照研究得出的知识，讨论了在这种计算中必须考虑的原则。
